nrclinonc
DESCRIPTION
Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis. Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapy Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175. - PowerPoint PPT PresentationTRANSCRIPT
Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis
Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapyNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175